At Pfizer Inc. their purpose is grounded in their commitment to fund programs that provide public benefit, advance medical care and improve patient outcomes. they believe that all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.
To address shortages of EpiPen, Pfizer is coordinating with FDA to extend the expiration dates of specific lots of EpiPen® 0.3 mg Auto-Injectors and its authorized generic version after review of stability data. Patients should have confidence in using the products from these particular lots as Pfizer works to stabilize supply, which is anticipated in the fourth-quarter of 2018. This announcement is based on a careful review of product stability data provided by Pfizer. We believe the extension of the expiration date will temporarily address patients access to and use of EpiPen® 0.3 mg Auto-Injectors, and the authorized generic, particularly during back-to-school season as demand increases.
Inquire before buying:
rnhttps://www.marketdataforecast.com/market-reports/mea-liver-disease-treatment-market-1738/inquire
Market Trends:
Market Data Forecast has released a report on Middle-East & Africa Liver Disease Treatment Market; chemotherapy segment in the market holds major share due to unorganized lifestyle, rising public awareness, growth in geriatric population, and unmet needs for the treatment of liver cancer. Additionally, spur in demand for alcohol has increased the risk of liver cirrhosis.
Middle-East & Africa Liver Disease Treatment Market is expected to reach USD 2.85 billion by 2023 from USD 2.85 billion in 2018, growing at a CAGR of 11.89% during the forecast period, 2018-2023.
Other major companies dominating Middle-East & Africa Liver Disease Treatment Market are Gilead Science Inc. (U.S.), Merck & Co. (U.S.), Johnson & Johnson (U.S.), Novartis (Switzerland), Roche (Switzerland), Sanofi-Aventis (France), Abbott Laboratories (U.S.), Bayer Schering AG (Germany), and AstraZeneca (United Kingdom).
For the detailed information please follow the link:
rnhttps://www.marketdataforecast.com/market-reports/mea-liver-disease-treatment-market-1738/
Scope of the Report:
The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.
The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.
What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
